Northern19 ,Safety, efficacy and determinants of response of allogeneic CD19-specific CAR-NK cells in CD19+ B cell tumors: a phase 1/2 trial | Nature Medicine,Leibniz Institute | EFM-19 | DSMZ,CELL SEARCH SYSTEM -CELL BANK- (RIKEN BRC) [RCB1450 : LM8],Leibniz Institute DSMZ: Details